Fort Washington Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.52M Sell
28,866
-176
-0.6% -$26.4K 0.02% 241
2026
Q1
$4.44M Sell
29,042
-295
-1% -$45.2K 0.02% 243
2025
Q4
$4.04M Sell
29,337
-191
-0.6% -$25K 0.02% 238
2025
Q3
$3.79M Sell
29,528
-647
-2% -$78.9K 0.02% 236
2025
Q2
$3.65M Sell
30,175
-1,050
-3% -$118K 0.02% 233
2025
Q1
$3.48M Sell
31,225
-1,610
-5% -$171K 0.02% 233
2024
Q4
$3.2M Sell
32,835
-1,090
-3% -$116K 0.02% 233
2024
Q3
$3.9M Sell
33,925
-700
-2% -$79.4K 0.02% 227
2024
Q2
$3.69M Sell
34,625
-60,692
-64% -$6.09M 0.02% 229
2024
Q1
$9.22M Sell
95,317
-550
-0.6% -$56.4K 0.06% 210
2023
Q4
$9.68M Sell
95,867
-231
-0.2% -$22.3K 0.07% 203
2023
Q3
$9.79M Sell
96,098
-1,084
-1% -$110K 0.07% 201
2023
Q2
$9.81M Sell
97,182
-396
-0.4% -$39.6K 0.07% 202
2023
Q1
$8.98M Hold
97,578
0.07% 206
2022
Q4
$8.85M Sell
97,578
-522
-0.5% -$44K 0.07% 203
2022
Q3
$7.46M Sell
98,100
-2,514
-2% -$208K 0.06% 211
2022
Q2
$8.51M Sell
100,614
-2,450
-2% -$215K 0.07% 204
2022
Q1
$9.04M Sell
103,064
-100
-0.1% -$8.66K 0.06% 206
2021
Q4
$9.02M Sell
103,164
-5,159
-5% -$428K 0.05% 213
2021
Q3
$8.86M Sell
108,323
-300
-0.3% -$27K 0.06% 216
2021
Q2
$9.91M Sell
108,623
-2,120
-2% -$189K 0.09% 205
2021
Q1
$9.47M Sell
110,743
-3,700
-3% -$332K 0.09% 202
2020
Q4
$10.8M Sell
114,443
-870
-0.8% -$76K 0.11% 130
2020
Q3
$10M Sell
115,313
-28,693
-20% -$2.49M 0.11% 120
2020
Q2
$12.6M Sell
144,006
-705,355
-83% -$60.9M 0.14% 113
2020
Q1
$70M Buy
849,361
+83,921
+11% +$7.49M 0.95% 30
2019
Q4
$72.5M Sell
765,440
-281,498
-27% -$25.3M 0.77% 34
2019
Q3
$91M Sell
1,046,938
-370,777
-26% -$33.3M 1.01% 26
2019
Q2
$129M Sell
1,417,715
-337,587
-19% -$28.6M 1.44% 13
2019
Q1
$151M Sell
1,755,302
-416,232
-19% -$33.4M 1.7% 10
2018
Q4
$167M Sell
2,171,534
-82,992
-4% -$6.46M 2.04% 7
2018
Q3
$174M Buy
2,254,526
+12,822
+0.6% +$948K 1.72% 9
2018
Q2
$152M Buy
2,241,704
+255,618
+13% +$17.6M 1.53% 9
2018
Q1
$144M Buy
1,986,086
+16,785
+0.9% +$1.28M 1.49% 11
2017
Q4
$148M Buy
1,969,301
+104,890
+6% +$7.91M 1.47% 11
2017
Q3
$143M Buy
1,864,411
+5,337
+0.3% +$403K 2.22% 6
2017
Q2
$139M Buy
1,859,074
+1,531
+0.1% +$109K 2.19% 7
2017
Q1
$124M Buy
1,857,543
+37,741
+2% +$2.51M 1.99% 9
2016
Q4
$119M Buy
1,819,802
+209,581
+13% +$13.6M 1.98% 12
2016
Q3
$114M Buy
1,610,221
+7,983
+0.5% +$582K 2.04% 12
2016
Q2
$118M Buy
1,602,238
+47,088
+3% +$3.25M 2.21% 10
2016
Q1
$101M Buy
1,555,150
+151,436
+11% +$10.3M 1.96% 11
2015
Q4
$108M Buy
1,403,714
+221,048
+19% +$17.6M 2.18% 10
2015
Q3
$97.4M Buy
1,182,666
+18,745
+2% +$1.67M 2.02% 13
2015
Q2
$103M Buy
1,163,921
+78,274
+7% +$7.18M 1.92% 14
2015
Q1
$95.9M Buy
1,085,647
+30,634
+3% +$2.72M 1.91% 15
2014
Q4
$87.6M Buy
1,055,013
+624,333
+145% +$51.8M 1.77% 15
2014
Q3
$36.3M Sell
430,680
-10,832
-2% -$876K 0.76% 39
2014
Q2
$35.8M Sell
441,512
-9,625
-2% -$757K 0.7% 41
2014
Q1
$34.4M Sell
451,137
-31,333
-6% -$2.28M 0.74% 40
2013
Q4
$34.8M Sell
482,470
-19,202
-4% -$1.33M 0.78% 36
2013
Q3
$34.5M Buy
501,672
+5,215
+1% +$345K 0.83% 33
2013
Q2
$31.5M Buy
+496,457
New +$32.3M 0.72% 31

Other funds holding NVS

Fort Washington Investment Advisors's NVS Position: Q2 2026 in Review

Fort Washington Investment Advisors reduced its Novartis (NVS) stake by 0.61% in Q2 2026, selling an estimated $26.4K and leaving 28,866 shares worth $4.52M. The position accounts for 0.02% of the portfolio, ranked #241.

Fort Washington Investment Advisors first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $174M in Q3 2018. 652 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Fort Washington Investment Advisors held 28,866 shares of Novartis worth $4.52M as of Q2 2026.
  • Fort Washington Investment Advisors sold 176 Novartis shares in Q2 2026, an estimated $26.4K.
  • Novartis made up 0.02% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #241 holding.
  • Fort Washington Investment Advisors first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Fort Washington Investment Advisors's Novartis position peaked at $174M in Q3 2018.
  • 652 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.